S.J. Ackerman

1.3k total citations
31 papers, 1.1k citations indexed

About

S.J. Ackerman is a scholar working on Rheumatology, Physiology and Immunology. According to data from OpenAlex, S.J. Ackerman has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 9 papers in Physiology and 9 papers in Immunology. Recurrent topics in S.J. Ackerman's work include Eosinophilic Disorders and Syndromes (15 papers), Asthma and respiratory diseases (7 papers) and Mast cells and histamine (4 papers). S.J. Ackerman is often cited by papers focused on Eosinophilic Disorders and Syndromes (15 papers), Asthma and respiratory diseases (7 papers) and Mast cells and histamine (4 papers). S.J. Ackerman collaborates with scholars based in United States, Japan and Sweden. S.J. Ackerman's co-authors include Gerald J. Gleich, Daniel G. Tenen, Helene F. Rosenberg, D A Loegering, G.J. Gleich, Ann M. Dvořàk, Per Venge, John B. Harley, Inge Olsson and A S Fauci and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Neuroscience.

In The Last Decade

S.J. Ackerman

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.J. Ackerman United States 17 472 440 378 317 170 31 1.1k
HD Campbell Australia 7 542 1.1× 588 1.3× 201 0.5× 258 0.8× 159 0.9× 8 1.3k
Anthony Marinov United States 16 580 1.2× 353 0.8× 178 0.5× 509 1.6× 89 0.5× 21 1.4k
David Steinmuller United States 20 778 1.6× 244 0.6× 246 0.7× 255 0.8× 520 3.1× 96 1.8k
Hidenori Yokoi Japan 17 552 1.2× 449 1.0× 172 0.5× 206 0.6× 316 1.9× 67 1.5k
Wenming Peng Germany 18 464 1.0× 335 0.8× 145 0.4× 171 0.5× 50 0.3× 32 1.2k
Javier Cote-Sierra United States 13 1.1k 2.4× 278 0.6× 56 0.1× 255 0.8× 186 1.1× 14 1.6k
Peter Van Vlasselaer United States 15 779 1.7× 186 0.4× 81 0.2× 255 0.8× 84 0.5× 46 1.4k
Chandra Raykundalia United Kingdom 13 1.6k 3.5× 180 0.4× 69 0.2× 269 0.8× 107 0.6× 21 2.0k
Gösta Roupe Sweden 19 520 1.1× 117 0.3× 266 0.7× 133 0.4× 77 0.5× 56 1.1k
Anja Köhler Germany 17 559 1.2× 144 0.3× 72 0.2× 267 0.8× 66 0.4× 32 1.2k

Countries citing papers authored by S.J. Ackerman

Since Specialization
Citations

This map shows the geographic impact of S.J. Ackerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.J. Ackerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.J. Ackerman more than expected).

Fields of papers citing papers by S.J. Ackerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.J. Ackerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.J. Ackerman. The network helps show where S.J. Ackerman may publish in the future.

Co-authorship network of co-authors of S.J. Ackerman

This figure shows the co-authorship network connecting the top 25 collaborators of S.J. Ackerman. A scholar is included among the top collaborators of S.J. Ackerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.J. Ackerman. S.J. Ackerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwatia, Mark A., et al.. (2003). Hydrolytic activites of phospholipase A2 and eosinophil lysophospholipases cause pulmonary surfactant dysfunction: A mechanism for small airway closure in asthma. Journal of Allergy and Clinical Immunology. 111(2). S345–S345. 1 indexed citations
3.
Kraft, Monica, et al.. (1995). Methacholine challenge does not affect bronchoalveolar fluid cell number and many indices of cell function in asthma. European Respiratory Journal. 8(11). 1966–1971. 18 indexed citations
4.
Dvořàk, Ann M., T Furitsu, Patricia Estrella, et al.. (1994). Ultrastructural localization of major basic protein in the human eosinophil lineage in vitro.. Journal of Histochemistry & Cytochemistry. 42(11). 1443–1451. 8 indexed citations
6.
Walbridge, Stuart, et al.. (1994). Toxicity of an antitumor ribonuclease to Purkinje neurons. Journal of Neuroscience. 14(2). 538–544. 54 indexed citations
7.
8.
Zon, LI, Yuji Yamaguchi, Karen O. Yee, et al.. (1993). Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood. 81(12). 3234–3241. 7 indexed citations
9.
Zon, LI, Yuji Yamaguchi, Karen O. Yee, et al.. (1993). Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood. 81(12). 3234–3241. 164 indexed citations
10.
Bennett, James P., et al.. (1991). 843 Potential role of the hematopoietic DNA-binding protein gata-1 in control of eosinophil specific gene transcription. Journal of Allergy and Clinical Immunology. 87(1). 350–350. 2 indexed citations
11.
Rosenberg, Helene F., S.J. Ackerman, & Daniel G. Tenen. (1989). Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity.. The Journal of Experimental Medicine. 170(1). 163–176. 132 indexed citations
12.
Dvořàk, Ann M. & S.J. Ackerman. (1989). Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils.. PubMed. 60(4). 557–67. 30 indexed citations
13.
Leung, Donald Y.M., Haifa H. Jabara, S.J. Ackerman, Donata Vercelli, & Raif S. Geha. (1988). 542 Induction of IgE synthesis and eosinophil (EOS) differentiation by supernatants (SUPS) of a human type 2 (Th2) helper t cell clone. Journal of Allergy and Clinical Immunology. 81(1). 303–303. 2 indexed citations
14.
15.
Ackerman, S.J., et al.. (1985). Calcium ionophore A23187 calcium-dependent cytolytic degranulation in human eosinophils.. The Journal of Immunology. 135(2). 1349–1356. 70 indexed citations
16.
Ackerman, S.J., G M Kephart, Thomas M. Habermann, PR Greipp, & Gerald J. Gleich. (1983). Localization of eosinophil granule major basic protein in human basophils.. The Journal of Experimental Medicine. 158(3). 946–961. 83 indexed citations
17.
Maddox, Daniel E., Joseph H. Butterfield, S.J. Ackerman, Carolyn B. Coulam, & Gerald J. Gleich. (1983). Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.. The Journal of Experimental Medicine. 158(4). 1211–1226. 52 indexed citations
18.
Ackerman, S.J., D A Loegering, Per Venge, et al.. (1983). Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.. The Journal of Immunology. 131(6). 2977–2982. 174 indexed citations
19.
Kierszenbaum, F, S.J. Ackerman, & Gerald J. Gleich. (1982). Inhibition of antibody-dependent eosinophil-mediated cytotoxicity by heparin.. The Journal of Immunology. 128(1). 515–517. 14 indexed citations
20.
Ackerman, S.J., Gerald J. Gleich, P F Weller, & Eric A. Ottesen. (1981). Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis.. The Journal of Immunology. 127(3). 1093–1098. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026